EMIT II PLUS OPIATE ASSAY, MODEL OSR9B229— 510(k) K011289

Name: FDA 510(k) clearance K011289
Creator: U.S. Food and Drug Administration
Published: 2001-05-15

Substantially Equivalent

Syva Co., Dade Behring, Inc.

FDA 510(k) clearance K011289 for EMIT II PLUS OPIATE ASSAY, MODEL OSR9B229, Substantially Equivalent on 2001-05-15. Applicant: Syva Co., Dade Behring, Inc.. Device class: 2.

Clearance details

Applicant: Syva Co., Dade Behring, Inc.
Product code: Code DJG
Device class: Class 2
Regulation: 21 CFR 862.3650
Advisory panel: Clinical Toxicology
Date received: 2001-04-27
Decision date: 2001-05-15
Decision: Substantially Equivalent
Clearance type: Special
Location: San Jose, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DJG

view all

K252684 — Labcorp Fentanyl Urine Visual Test2026-01-29
K250741 — Evidence MultiSTAT DOA Urine MultiPlex2026-01-23
K253082 — LZI Buprenorphine II Enzyme Immunoassay2026-01-16
K252520 — SEFRIA Hydrocodone Oral Fluid2025-09-11
K251972 — Healgen® AccuFluor Fentanyl Fluorescence Immunoassay (FIA)Test Kit - Qualitative +1 more2025-08-15

More clearances from Syva Co., Dade Behring, Inc.

view all

K011920 — EMIT 2000 DIGOXIN ASSAY, MODEL OSR4H2292001-07-02
K011620 — EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N2292001-06-18
K011605 — EMIT 2000 QUINIDINE ASSAY, MODEL OSR4Q2292001-06-12
K011300 — EMIT II PLUS CANNABINOID ASSAY, MODEL OSR9N2292001-05-17
K011306 — EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F2292001-05-16

Data sourced from openFDA. This site is unofficial and independent of the FDA.